Co-founder of GIOSTAR. Dr. Anand Srivastava is a world-renowned authority in the field of stem cell science, also known as regenerative medicine.
Dr. Srivastava’s interdisciplinary approach to medicine stems from his almost two-decades-long experience in the field of stem cell research. He has expertise in protein biochemistry, molecular biology, immunology, stem cell biology, in utero transplantation, tissue targeting, clinical research, immunology, and gene therapy.
Dr. Srivastava is engaged in ongoing research and he has helped develop the stem cell research programs for prestigious institutions in the U.S, such as the University of California San Diego (UCSD), Salk Research Institute, San Diego, California, University of California Irvine (UCI), Burnham Institute of Medical Research, San Diego, California and University of California Los Angeles (UCLA).
Dr. Srivastava's efforts have been recognized on an international level, namely at conferences in the United States, Japan, Germany, Korea, China, and India. He has been published in leading medical journals.
His work was instrumental in the progression of stem cell science in the field of stem cell neurology at the University of California, San Diego (UCSD). Between 2002 and 2006, he was involved in studying the role of stem cells in repairing damaged portions of the animal brain. Dr. Srivastava’s research expertise in characterizing new genes are monumental for GIOSTAR to continue developing effective therapies and remain at the forefront of their everchanging field of regenerative medicine.
Dr. Srivastava was the recipient of the Congressional Award, as well as two consecutive JISTEC awards (Japan International Science and Technology Exchange)
He has translated his research into what GIOSTAR has become today: a global institute that focuses on developing the therapies for degenerative diseases, genetic diseases, and cancer.